Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Minimizing spending doesn’t have to be a challenge. Explore effortless ways to keep your expenses low while enjoying life.
22,570 articlesA biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Policy clarity cleared a Senate hurdle, but bitcoin demand weakens despite the CLARITY Act win as ETF buyers pull bac...
A fresh look at history shows disciplined buyers beat market timers over lengthy, stagnant periods. The counterintuit...
A Florida biologist and state agency reach a $485,000 settlement over her firing tied to social media comments about ...
Parsons Corp faces a tough mix: a record backlog rising margins boost profitability, yet an upcoming policy and contr...
As AI fuels energy needs, NuScale’s small modular reactors offer a faster, scalable path to cleaner power. This guide...
SpaceX is positioning Starship V3 as the backbone of an IPO that could redefine private markets. Analysts say the nex...
As the last Baby Boomers retire, their influence lingers in wages, homes, and boardrooms. This report explains how th...
Pension funds are aggressively loading up on the Vanguard Intermediate-Term Government Bond ETF, a move that highligh...
America marks 250 years with a focus on risk-sharing as the true engine of progress. The greatest lesson may be the b...
Squid Crypto raised $6 million with Ripple backing, only to see $3 million drained in a 24-hour window as a periphera...
A new wave of skepticism surrounds the Fed after a high-profile critique from a former governor. This piece explains ...